UnitedHealth Group attracts fresh analyst support, shares trade near recent highs

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 13:02.

UnitedHealth Group (US91324P1021) sits close to recent highs on the NYSE after a strong rebound in its shares over the past two months. Several major research houses have lifted their price targets on the S&P 500 health insurer in June, providing a clear consensus backdrop.MarketScreener data on UNH and analyst actions

What recent analyst revisions show

Bank of America Securities adjusted its price target on UnitedHealth Group from 450 to 475 US dollars on June 24, while maintaining a positive stance on the NYSE-listed shares.BofA Securities target change reported by MarketScreener Earlier in June, Leerink Partners raised its target from 400 to 462 dollars and reiterated an Outperform rating, underlining expectations for continued earnings strength in UnitedHealth's health insurance and services operations.Leerink Partners update on UnitedHealth Group

Additional analyst commentary compiled by MarketScreener shows several buy or outperform recommendations from houses such as UBS, Truist Securities and Bernstein, each lifting their price targets during the recent recovery phase in the UnitedHealth Group shares.TrendSpider summary of recent analyst calls on UNH This clustered upward revision pattern supports the view of UnitedHealth as a defensive health-care component within the S&P 500, with analysts pointing to earnings visibility and scale advantages.

Consensus picture and share performance

UnitedHealth Group is part of the Dow Jones Industrial Average and the S&P 500, making it a core US health-care benchmark for global investors.Bitget profile on UnitedHealth Group and index membership MarketScreener data show the shares at 427.89 US dollars at the close on June 26, 2026, a roughly 6.7 percent gain since the start of the year and close to the 52-week high after a nearly 40 percent recovery in two months.MarketScreener quote and performance metrics for UNH

Recent commentary highlights defensive-sector buying and optimism around earnings as key drivers of the move rather than a single company-specific headline.MarketBeat overview of factors behind UNH share performance With UnitedHealth shares trading near their recent highs on the NYSE, the stock continues to feature in sector comparisons with other large US health insurers such as Elevance Health and Cigna, where scale and diversified health-services exposure are frequently cited as differentiating factors.

The business behind UnitedHealth Group

UnitedHealth Group generates most of its revenue through its health insurance operations under the UnitedHealthcare brand, covering employer-sponsored, individual and government plans across the United States.UnitedHealth Group corporate overview A second major pillar is Optum, which provides health-care services, data analytics and pharmacy-benefit management, giving the group a diversified business model across insurance and care delivery.

Where the UnitedHealth Group shares trade today

UnitedHealth Group shares (US91324P1021) most recently traded at around 427.89 US dollars on the NYSE on 2026-06-26, 21:00, according to MarketScreener data, reflecting a year-to-date gain of about 6.7 percent in US dollars.MarketScreener closing price and performance figures for UNH

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data have been compiled with care from publicly available sources but without guarantee. Investors should conduct their own research and, where appropriate, consult a qualified financial adviser.